Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.9602
+0.0472 (5.17%)
At close: Aug 4, 2026, 4:00 PM EDT
0.9575
-0.0027 (-0.28%)
After-hours: Aug 4, 2026, 4:18 PM EDT

Outlook Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Cap
1805712858277383
Market Cap Growth
117.10%-55.25%121.94%-79.26%-27.58%318.16%
Enterprise Value
185.8979.23142.4769.68270.88380.35
Last Close Price
0.961.065.344.4224.4043.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
499.6340.41----
PB Ratio
--1.77-1.75-3.9831.7483.11
P/TBV Ratio
----29.6271.91

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
557.9856.05----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
-0.39-0.010.0000.002.37
Net Debt / Equity Ratio
-0.67-0.69-0.20-0.84-0.74-0.56
Net Debt / EBITDA Ratio
-0.32-0.33-0.21-0.230.100.05
Net Debt / FCF Ratio
-0.41-0.43-0.21-0.280.110.05
Asset Turnover
0.020.060000
Inventory Turnover
0.450.81----
Quick Ratio
0.270.210.350.500.882.14
Current Ratio
0.540.380.640.661.393.19
Return on Equity (ROE)
180.49%118.61%172.24%2069.13%-989.99%-1430.33%
Return on Assets (ROA)
-289.99%-276.05%-234.63%-174.69%-245.71%-243.18%
Return on Invested Capital (ROIC)
-----2913.12%-
Return on Capital Employed (ROCE)
253.40%327.44%509.22%1886.06%-507.46%-519.79%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Buyback Yield / Dilution
-121.62%-87.59%-48.29%-17.96%-38.91%-110.43%
Total Shareholder Return
-121.62%-87.59%-48.29%-17.96%-38.91%-110.43%
SEC Filings: 10-K · 10-Q